ESR1 and breast carcinoma: Finally, the breast cancer and integrated cancer pathways were enriched using WikiPathways, along with the PI3K-AKT-mTOR signaling pathway and therapeutic opportunities, EGFR tyrosine kinase inhibitor resistance, and the androgen and estrogen receptor signaling pathways (Supplementary File S1E).